Orgenesis Inc. (ORGS)
OTCMKTS
· Delayed Price · Currency is USD
1.180
+0.080 (7.27%)
Nov 18, 2024, 9:30 AM EST
Orgenesis Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Revenue | 0.9 | 0.53 | 36.03 | 35.5 | 7.65 | 3.9 | Upgrade
|
Revenue Growth (YoY) | -93.57% | -98.53% | 1.47% | 363.96% | 96.26% | -82.46% | Upgrade
|
Cost of Revenue | 1.78 | 6.26 | 5.13 | - | - | - | Upgrade
|
Gross Profit | -0.88 | -5.73 | 30.89 | 35.5 | 7.65 | 3.9 | Upgrade
|
Selling, General & Admin | 12.93 | 35.13 | 15.59 | 14.71 | 18.29 | 11.45 | Upgrade
|
Research & Development | 11.39 | 10.62 | 21.93 | 36.64 | 83.99 | 14.01 | Upgrade
|
Other Operating Expenses | - | - | - | - | - | -0.02 | Upgrade
|
Operating Expenses | 25.04 | 46.48 | 38.43 | 52.3 | 102.76 | 25.87 | Upgrade
|
Operating Income | -25.92 | -52.2 | -7.54 | -16.8 | -95.1 | -21.98 | Upgrade
|
Interest Expense | -2.81 | -2.17 | -1.82 | -0.94 | -1.25 | -0.5 | Upgrade
|
Earnings From Equity Investments | -0.18 | -0.73 | -1.51 | -0.27 | 0.11 | - | Upgrade
|
Currency Exchange Gain (Loss) | -0.01 | -0.33 | -0.15 | -0.57 | -0.16 | -0.4 | Upgrade
|
Other Non Operating Income (Expenses) | -4.56 | -0 | 0.17 | 2.5 | 0.36 | 0.05 | Upgrade
|
EBT Excluding Unusual Items | -33.49 | -55.43 | -10.85 | -16.09 | -96.05 | -22.82 | Upgrade
|
Merger & Restructuring Charges | - | - | - | - | -0.68 | - | Upgrade
|
Gain (Loss) on Sale of Investments | -0.7 | -0.7 | - | - | - | - | Upgrade
|
Gain (Loss) on Sale of Assets | -0.07 | -5.34 | - | - | - | - | Upgrade
|
Asset Writedown | -0.69 | - | -1.06 | - | - | - | Upgrade
|
Other Unusual Items | -0.4 | -2.97 | -0.05 | -1.87 | - | - | Upgrade
|
Pretax Income | -35.35 | -64.45 | -11.96 | -17.95 | -96.74 | -22.82 | Upgrade
|
Income Tax Expense | -0.09 | 0.47 | 0.21 | 0.11 | -1.61 | -0.23 | Upgrade
|
Earnings From Continuing Operations | -35.26 | -64.92 | -12.17 | -18.06 | -95.13 | -22.59 | Upgrade
|
Earnings From Discontinued Operations | - | - | - | - | 96.2 | -1.63 | Upgrade
|
Net Income to Company | -35.26 | -64.92 | -12.17 | -18.06 | 1.07 | -24.22 | Upgrade
|
Minority Interest in Earnings | 0.85 | 9.56 | -2.72 | 0.01 | 0.04 | 0.1 | Upgrade
|
Net Income | -34.41 | -55.36 | -14.89 | -18.05 | 1.11 | -24.12 | Upgrade
|
Preferred Dividends & Other Adjustments | - | - | - | - | -5.16 | 4.1 | Upgrade
|
Net Income to Common | -34.41 | -55.36 | -14.89 | -18.05 | 6.27 | -28.22 | Upgrade
|
Shares Outstanding (Basic) | 4 | 3 | 3 | 2 | 2 | 2 | Upgrade
|
Shares Outstanding (Diluted) | 4 | 3 | 3 | 2 | 2 | 2 | Upgrade
|
Shares Change (YoY) | 34.70% | 15.59% | 3.39% | 13.85% | 34.02% | 3.14% | Upgrade
|
EPS (Basic) | -9.23 | -19.08 | -5.93 | -7.44 | 2.94 | -17.74 | Upgrade
|
EPS (Diluted) | -11.20 | -19.08 | -5.93 | -7.44 | 2.94 | -17.74 | Upgrade
|
Free Cash Flow | -15.74 | -16.93 | -37.34 | -34.73 | -79.57 | -25.35 | Upgrade
|
Free Cash Flow Per Share | -4.22 | -5.84 | -14.88 | -14.31 | -37.32 | -15.93 | Upgrade
|
Gross Margin | -97.66% | - | 85.75% | 100.00% | 100.00% | 100.00% | Upgrade
|
Operating Margin | -2883.31% | -9849.62% | -20.93% | -47.32% | -1242.85% | -563.61% | Upgrade
|
Profit Margin | -3827.81% | -10445.47% | -41.33% | -50.85% | 81.94% | -723.67% | Upgrade
|
Free Cash Flow Margin | -1751.17% | -3194.91% | -103.65% | -97.83% | -1039.87% | -650.14% | Upgrade
|
EBITDA | -24.1 | -50.64 | -5.56 | -15.58 | -94.56 | -20.91 | Upgrade
|
EBITDA Margin | - | - | -15.44% | -43.88% | - | - | Upgrade
|
D&A For EBITDA | 1.82 | 1.56 | 1.98 | 1.22 | 0.54 | 1.06 | Upgrade
|
EBIT | -25.92 | -52.2 | -7.54 | -16.8 | -95.1 | -21.98 | Upgrade
|
EBIT Margin | - | - | -20.93% | -47.32% | - | - | Upgrade
|
Revenue as Reported | 0.42 | 0.53 | 36.03 | 35.5 | 7.65 | 3.9 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.